Latest AI and machine learning research in oncology/hematology for healthcare professionals.
AIM: This study evaluates the comparative effectiveness of pathologists versus artificial intelligence (AI) algorithms in scoring PD-L1 expression in non-small cell lung carcinoma (NSCLC). Immune-checkpoint inhibitors have revolutionized NSCLC treatment, with PD-L1 expression, measured as the tumour proportion score (TPS), serving as a critical predictive biomarker for therapeutic response.
Artificial intelligence (AI) has become a pivotal tool for medical image analysis, significantly enhancing drug discovery through improved diagnostics, staging, prognostication, and response assessment. At a high level, AI-driven image analysis enables the quantification and synthesis of previously qualitative imaging characteristics, facilitating the identification of novel disease-specific bioma...
Brain tumors pose a significant threat to human health, require a precise and quick diagnosis for effective treatment. However, achieving high diagnos...
Integrating artificial intelligence (AI) into radiation oncology has revolutionized clinical workflows, enhancing efficiency, safety, and quality. How...
BACKGROUND: The ability of machine learning (ML) to process and learn from large quantities of heterogeneous patient data is gaining attention in the ...
BACKGROUND: The clinical information housed within unstructured electronic health records (EHRs) has the potential to promote cancer research. The Nat...
To enhance the diagnostic accuracy of new nodules on the surgical side after breast cancer surgery using machine learning techniques and to explore t...
BACKGROUND: Perineural invasion (PNI) is an independent prognostic risk factor for gallbladder carcinoma (GBC). However, there is currently no reliabl...
The morphological characteristics of pulmonary nodule, also known as the attributes, are crucial for classification of benign and malignant nodules. I...
The objective of this study was to employ machine learning to identify shared differentially expressed genes (DEGs) in prostate cancer (PCa) initiatio...
BACKGROUND: Immunotherapy has revolutionized the treatment landscape for head and neck squamous cell carcinoma (HNSCC) and PD-L1 combined positivity s...
Cell classification based on histopathology images is crucial for tumor recognition and cancer diagnosis. Using deep learning, classification accuracy...
The segmentation of breast cancer diagnosis and medical imaging contains issues such as noise, variation in contrast, and low resolutions which make i...
RATIONALE AND OBJECTIVES: Immunotherapy combined with chemotherapy has improved outcomes for some esophageal squamous cell carcinoma (ESCC) patients, ...
BACKGROUND AND OBJECTIVE: Scalable, flexible and highly interpretable tools for predicting mortality in residential aged care facilities for the purpo...
Contrast-enhanced ultrasound (CEUS) plays a pivotal role in the diagnosis of primary breast cancer and in axillary lymph node (ALN) metastasis. Howeve...
Heart failure (HF) is a complex and prevalent condition, particularly in the elderly, presenting symptoms like chest tightness, shortness of breath, a...
BACKGROUND: Dysregulation or abnormality of the programmed cell death (PCD) pathway is closely related to the occurrence and development of many tumor...
Over 90% of gastrointestinal stromal tumors (GISTs) harbor mutations in KIT or PDGFRA that can predict response to tyrosine kinase inhibitor (TKI) the...
BACKGROUND: Radiomics analysis extracts high-dimensional features from medical images, which are used to predict outcomes in machine learning (ML). Re...